AMN Healthcare Board Appoints Daphne Jones as New Independent Director
AMN Healthcare Services, Inc., the leader and innovator in healthcare workforce solutions and staffing services, announced that its Board of Directors has appointed Daphne E. Jones as a new independent director. With the election of Ms. Jones, the size of AMN Healthcare’s Board of Directors increases from eight to nine members.
Ms. Jones is an accomplished and seasoned executive with extensive experience in strategic, entrepreneurial and global use of digital technologies within multi-national corporations. She has over 30 years of experience in general management and executive level roles at IBM, Johnson & Johnson, Hospira (now Pfizer) and GE Healthcare. In her most recent tenure at GE, she served in roles including Senior Executive for Future of Work; Chief Information Officer for Product Engineering, Imaging, and Ultrasound; and Chief Information Officer for Global Services – all comprising a $13 billion segment within GE Healthcare.
Since her retirement from GE Healthcare in 2017, Ms. Jones has been serving as an independent director on public and not-for-profit boards, including Masonite International and the Thurgood Marshall College Fund.
“Daphne’s addition to our Board of Directors is very exciting and will make a positive impact in the evolution of AMN Healthcare,” said Susan Salka, President and CEO. “Her significant experience and passion for transformative technology solutions and redefining business models will provide important insights and contributions to the continuing success of our company. AMN Healthcare is committed to regularly refreshing and strengthening our Board, and Daphne is a perfect match for the experiences and values we were seeking.”
“I am looking forward to joining the Board of Directors at AMN and contributing to this innovative company,” said Ms. Jones. “I’m excited to be part of AMN’s work in transforming the way healthcare organizations can effectively manage their staffing at all levels, while also achieving financial, operational and clinical goals.”